| scholarly article | Q13442814 |
| P2093 | author name string | Jonathan R Lindner | |
| Jeanne Link | |||
| P2860 | cites work | Molecular imaging in drug development | Q22122025 |
| Nanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 1: Compositions and Features | Q26798426 | ||
| Oxygenation-sensitive cardiovascular magnetic resonance | Q27027538 | ||
| Molecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis | Q27339951 | ||
| Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis | Q28255335 | ||
| How to improve R&D productivity: the pharmaceutical industry's grand challenge | Q28314992 | ||
| Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes | Q30304696 | ||
| Imaging inflammation and neovascularization in atherosclerosis: clinical and translational molecular and structural imaging targets | Q30370897 | ||
| FDA Facilitated Regulatory Pathways: Visualizing Their Characteristics, Development, and Authorization Timelines. | Q30377595 | ||
| Multimodality cardiovascular molecular imaging, Part II | Q30438207 | ||
| Molecular imaging in cardiovascular disease: Which methods, which diseases? | Q30442045 | ||
| Molecular imaging of the paracrine proangiogenic effects of progenitor cell therapy in limb ischemia | Q30443135 | ||
| Noninvasive ultrasound molecular imaging of the effect of statins on endothelial inflammatory phenotype in early atherosclerosis | Q30455730 | ||
| Dysregulated selectin expression and monocyte recruitment during ischemia-related vascular remodeling in diabetes mellitus | Q30461411 | ||
| Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation | Q30484224 | ||
| Molecular imaging of activated matrix metalloproteinases in vascular remodeling | Q30485880 | ||
| Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography. | Q30658182 | ||
| Neuroimaging in Parkinson disease: from research setting to clinical practice | Q30868628 | ||
| Superior efficacy of new medicines? | Q33785599 | ||
| Real-time imaging of oxidative and nitrosative stress in the liver of live animals for drug-toxicity testing. | Q33804664 | ||
| Molecular imaging of angiogenic therapy in peripheral vascular disease with alphanubeta3-integrin-targeted nanoparticles | Q34033191 | ||
| Different capacity of monocyte subsets to phagocytose iron-oxide nanoparticles | Q34044843 | ||
| Principles of early drug discovery | Q34150775 | ||
| Molecular imaging of endothelial vascular cell adhesion molecule-1 expression and inflammatory cell recruitment during vasculogenesis and ischemia-mediated arteriogenesis | Q47680752 | ||
| Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study | Q48952305 | ||
| Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. | Q50507177 | ||
| Advances in cardiovascular molecular imaging for tracking stem cell therapy. | Q50701050 | ||
| Folate receptor-β imaging using 99mTc-folate to explore distribution of polarized macrophage populations in human atherosclerotic plaque. | Q53042870 | ||
| Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis | Q56894441 | ||
| 2-deoxy-2-[18F]fluoro-d-mannose positron emission tomography imaging in atherosclerosis | Q56985984 | ||
| Molecular Imaging of Hypoxia | Q57574310 | ||
| Imaging the Migration of Therapeutically Delivered Cardiac Stem Cells | Q58071222 | ||
| Molecular imaging of macrophage protease activity in cardiovascular inflammation in vivo | Q58816167 | ||
| Optical Visualization of Cathepsin K Activity in Atherosclerosis With a Novel, Protease-Activatable Fluorescence Sensor | Q58816186 | ||
| 2016 FDA drug approvals | Q89919917 | ||
| Early stem cell engraftment predicts late cardiac functional recovery: preclinical insights from molecular imaging | Q34260802 | ||
| Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction | Q34380380 | ||
| Photodynamic therapy using a protease-mediated theranostic agent reduces cathepsin-B activity in mouse atheromata in vivo | Q34641608 | ||
| Myocardial substrate and route of administration determine acute cardiac retention and lung bio-distribution of cardiosphere-derived cells | Q35101081 | ||
| Current progress in Structure-Based Rational Drug Design marks a new mindset in drug discovery | Q35136572 | ||
| Nanomedical Theranostics in Cardiovascular Disease. | Q35681183 | ||
| Molecular imaging of mesenchymal stem cell: mechanistic insight into cardiac repair after experimental myocardial infarction | Q35739930 | ||
| Molecular imaging of aortic aneurysms. | Q36066718 | ||
| Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development | Q36141999 | ||
| Estimated 10-year cardiovascular mortality seriously underestimates overall cardiovascular risk | Q36475652 | ||
| Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. | Q36617730 | ||
| Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis | Q37085672 | ||
| Diagnostic and prognostic imaging of the cardiac sympathetic nervous system | Q37222196 | ||
| Proinflammatory endothelial activation detected by molecular imaging in obese nonhuman primates coincides with onset of insulin resistance and progressively increases with duration of insulin resistance | Q37540095 | ||
| Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. | Q37640011 | ||
| Cardiac sympathetic imaging with mIBG in heart failure | Q37686799 | ||
| A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation | Q37727091 | ||
| Approaches to multimodality imaging of angiogenesis | Q37748299 | ||
| Imaging macrophage development and fate in atherosclerosis and myocardial infarction | Q38064660 | ||
| Molecular imaging: the key to advancing cardiac stem cell therapy | Q38096580 | ||
| The role of molecular imaging in modern drug development | Q38179143 | ||
| Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial. | Q38399446 | ||
| Folate receptor–targeted single-photon emission computed tomography/computed tomography to detect activated macrophages in atherosclerosis: can it distinguish vulnerable from stable atherosclerotic plaques? | Q38709170 | ||
| Trends In Orphan New Molecular Entities, 1983-2014: Half Were First In Class, And Rare Cancers Were The Most Frequent Target | Q38765034 | ||
| Introducing Therioepistemology: the study of how knowledge is gained from animal research. | Q39193369 | ||
| Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events | Q39309074 | ||
| Chitosan-based nanogels for selective delivery of photosensitizers to macrophages and improved retention in and therapy of articular joints | Q39740207 | ||
| Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. | Q40251686 | ||
| Why the drug development pipeline is not delivering better medicines | Q40397865 | ||
| Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo | Q41612083 | ||
| Targeted imaging of the spatial and temporal variation of matrix metalloproteinase activity in a porcine model of postinfarct remodeling: relationship to myocardial dysfunction | Q41829618 | ||
| 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis | Q42616070 | ||
| Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study | Q43147933 | ||
| Annexin A5 uptake in ischemic myocardium: demonstration of reversible phosphatidylserine externalization and feasibility of radionuclide imaging | Q43177675 | ||
| Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice | Q43266220 | ||
| Impact of high-throughput screening in biomedical research | Q45352809 | ||
| The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. | Q45992172 | ||
| Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction | Q46167122 | ||
| P433 | issue | 2 | |
| P921 | main subject | drug discovery | Q1418791 |
| P304 | page(s) | e005355 | |
| P577 | publication date | 2018-02-01 | |
| P1433 | published in | Circulation: Cardiovascular Imaging | Q3332375 |
| P1476 | title | Molecular Imaging in Drug Discovery and Development. | |
| P478 | volume | 11 |
| Q96017759 | Molecular imaging in lymphoma beyond 18F-FDG-PET: understanding the biology and its implications for diagnostics and therapy |
| Q99419109 | Multiplexed non-invasive tumor imaging of glucose metabolism and receptor-ligand engagement using dark quencher FRET acceptor |
| Q98891737 | Quantifying drug tissue biodistribution by integrating high content screening with deep-learning analysis |
Search more.